• Maintain healthy immune system regulation.
• Reduce occurrence of, and manage, allergy symptoms.
• Decrease occurrence of eczema in infants and children. Eczema affects up to 1 in 3 children.
• Combination of two immune modulating, anti-inflammatory probiotic strains.
  

Clinical benefits:

• Lactobacillus rhamnosus LGG® and Lactobacillus paracasei (LP-33™) help to promote immune regulation by interacting with dendritic cells within the gut associated lymphoid tissue (GALT) stimulating the production of regulatory T cells and increasing production of regulatory cytokines such as IL-10 and TGF-beta.
• LGG® promotes a shift towards an enhanced anti-inflammatory response by a heightened secretion of anti-inflammatory cytokines and decreased secrtion of pro-inflammatory cytokines.
• LGG® has bidirectional immunomodulatory effects - stimulatory when an increased response is needed and down-regulatory when attenuation is appropriate.
• LP-33™ modulates inflammation and immune reactions by interacting with these cells ans, together with LGG®, inducing development of regulatory T cells which can down regulate IgE, a Th2 cytokine involved in allergy.